Sublingual Allergy Immunotherapy Market Size, Industry Analysis, Growth, Challenges and Opportunities Report by 2033
Introduction:
The sublingual allergy immunotherapy (SLIT) market achieved a milestone by reaching US$ 414.5 million in 2022, with a projected Compound Annual Growth Rate (CAGR) of 9.1%. This expansion is anticipated to propel the market to US$ 1.02 billion by the close of 2033.
According to assessments by Persistence Market Research, the Odactra drug secured a dominant market share of 40.1% in 2022, while sublingual allergy immunotherapy contributed to a 2% share of the global allergy treatment market. A notable surge in the prevalence of allergic disorders, such as food allergies, allergic rhinitis, atopic dermatitis, and allergic rhinitis, has been observed in recent years.
A 2019 study published in the National Library of Medicine indicates that 20% of the global population is collecti...